Our results revealed that the frequency of p16 gene methylation in carcinoma tissues was significantly higher than normal tissues (the overall OR = 13.41, 95% CI = 9.18–19.59, p < 0.00001). This evidence concerns the gene CDKN2A and carcinoma.